Favor Cyclicals Over Defensives Over The Coming Year
Published on
Global cyclical stocks gained ground versus their defensive counterparts this week in response to Pfizer’s vaccine efficacy news, setting a new post-March high. While cyclicals paused modestly on Wednesday as investors continued to digest the news,…
Interested in reading the full Daily Insight?
Read the full insight with instant access.
BCA Research | Essentials
Base-level subscription for all clients. Includes Bank Credit Analyst, BCA Live (formerly BCA Live & Unfiltered), and BCA Daily Insights.
Stay Connected with BCA
Get our latest events and research insights delivered to your inbox.